LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

COMBINED LDL-C AND LIPOPROTEIN (A) LEVELS IN PREDICTION OF RESIDUAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK: THE AIM-HIGH TRIAL (ATHEROTHROMBOSIS INTERVENTION IN METABOLIC SYNDROME WITH LOW HDL/HIGH TRIGLYCERIDES: IMPACT ON GLOBAL HEALTH OUTCOMES)

Photo by nci from unsplash

Background: In patients with atherosclerotic cardiovascular disease (ASCVD), the relationship of lipoprotein(a) [Lp(a)] levels with ASCVD outcomes when LDL-C levels are controlled remains unclear. Methods: We studied 3,196 patients with… Click to show full abstract

Background: In patients with atherosclerotic cardiovascular disease (ASCVD), the relationship of lipoprotein(a) [Lp(a)] levels with ASCVD outcomes when LDL-C levels are controlled remains unclear. Methods: We studied 3,196 patients with ASCVD in the AIM-HIGH trial, all of whom were on statin

Keywords: atherosclerotic cardiovascular; aim high; lipoprotein levels; cardiovascular disease; high trial

Journal Title: Journal of the American College of Cardiology
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.